This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Newsletter Archive
Men's Health Weekly
Uroalerts Men's Health Weekly
December 16, 2025
Videos
Peer-to-Peer Clinical Conversations
Bladder-Centric Focus in BPH: Early Triage and a Five-Stage Model - Wayne Kuang
Wayne Kuang discusses his ManVsProstate initiative with Alan Wein, emphasizing bladder health preservation in BPH.
View
Preoperative Urinary Retention and Its Effect on HoLEP Surgery Outcomes - Diana Lopategui
Alan Wein hosts Diana Lopategui to present a retrospective database analysis examining whether chronic urinary retention severity impacts HoLEP outcomes.
View
Beyond the Abstracts
Identification of Missense DMC1 Variants in Males with Non-Obstructive Azoospermia - Beyond the Abstract
A Critical Analysis of the Methodological Limitations in Trials of Low-Intensity Shockwave Therapy for Erectile Dysfunction - Beyond the Abstract
Conference Coverage
SUO 2025: Open versus Robotic Post-Chemotherapy Retroperitoneal Lymph Node Dissection: A Propensity Score Matched Study Across Eleven Academic Centers
ESMO 2025: Final Results of the COTRIMS (COlogne Trial of Retroperitoneal Lymphadectomy in Metastastic Seminoma) Trial
ESMO 2025: Post-Diagnosis Paternity in Testicular Cancer Survivors: A Controlled Cohort Study
Articles
Editor Selected Abstracts and Commentaries
Male Infertility
Fertility Prospects Among Testicular Cancer Survivors: Outcomes of Surgical Sperm Retrieval in Azoospermic Patients.
Constructing a nomogram for ICSI-ET assisted reproductive outcomes in infertile men based on lifestyle and sperm quality: a multicenter retrospective survey.
Distinct Post-Insemination Dynamics Between Fresh and Frozen-Derived Gametes Using Testicular Sperm - Beyond the Abstract
The Role of Sperm DNA Fragmentation in Reproduction: A SWOT Analysis - Beyond the Abstract
Peyronie's Disease
Management of Peyronie's disease: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024).
Cost Consideration for the Treatment of Peyronie's Disease: A Narrative Review.
Erectile Dysfunction
Association Between Rectal Spacer Use and Erectile Dysfunction Diagnosis Among Men Receiving Prostate Radiotherapy: US County-Level Analysis.
Erectile and urinary function in patients on active surveillance for prostate cancer: results from the Finnish arm of the PRIAS trial.
Exploring the relationship between social determinants of health and erectile dysfunction using the NHANES survey.
A Critical Analysis of the Methodological Limitations in Trials of Low-Intensity Shockwave Therapy for Erectile Dysfunction - Beyond the Abstract
BPH - Benign Prostatic Enlargement
12-Month Outcomes from a Randomized, Sham Controlled Trial Evaluating a Novel Prostatic Urethral Stent for the Treatment of Benign Prostatic Hyperplasia.
TERT expression in human prostate tissue reveals a potential molecular switch in benign prostatic hyperplasia progression.
Introduction of a Structured Reporting Protocol and Surgical Checklist for Rezum Water Vapor Therapy (VAPOR-SRP).
Do patients Rezum medications?-a real-world analysis of medical retreatment after water vapor thermal therapy.
Thulium fibre laser endoscopic enucleation of the prostate (THUFLEP) learning curve assessment: A retrospective analysis of the experience of a single surgeon.
FDA Approves the ProVee System - The First of a New Generation of Prostatic Urethral Stents for Treatment of BPH
Assessment of the Validity of ChatGPT-3.5 Responses to Patient-Generated Queries Following BPH Surgery - Beyond the Abstract
Penile & Urethral Cancers
Understanding Chronic Opioid Use Risk Associated with Penile Cancer Treatments: A National Analysis.
Sexual Function After Laser Therapy for Penile Cancer: A Systematic Review.
Testicular Cancer
Molecular pathology of testicular germ cell tumours: an update for practicing pathologists.
Targeting the LINC01272-FUS signal axis inhibits the migration and invasion of testicular germ cell tumors.
Can novel biomarkers augment traditional surveillance paradigms in early-stage testicular germ cell tumors? A case study in pre-clinical relapse detection using a combination micro-RNA-371a-3p and 372-3p assay.
MicroRNA as a Liquid Biomarker to Detect Malignancy in Small Testicular Masses - Beyond the Abstract
Prostate Cancer
Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosis.
Prostate cancer molecular subtypes in systematic versus MRI-targeted biopsy cores at active surveillance: association of PTEN and ERG status with extreme grade reclassification.
Graded Notch Signaling Functions as a Rheostat of Lineage Plasticity and Therapy Resistance in Prostate Cancer.
Prostate MRI in the UK: a survey of current practice by the British Society of Urogenital Radiology.
Palliative and hospice care in prostate cancer: A scoping review.
Ethnic Differences in Response Rate and Patient-Reported Outcomes at Baseline and 12 Months Post-Treatment Among New Zealand Men With Prostate Cancer.
Cost Effectiveness of Local Anaesthetic Transperineal Versus Transrectal Biopsy: Results from the TRANSLATE Study.
Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis.
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer-Oncological Outcome from Long-term Follow-up.
Analysis of Operator Expertise in MRI/TRUS Fusion-Guided Prostate Biopsy.
FDA Approves Niraparib and Abiraterone Acetate plus Prednisone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations.
Monoclonal Gammopathy Prevalence in Newly Diagnosed Prostate Cancer Patients: A Correlative Perspective Observational Study.
Therapeutic Advances in Metastatic Prostate Cancer: A Journey from Standard of Care to New Emerging Treatment.
Real World Hospitalizations in US Veterans Treated for Metastatic Prostate Cancer with Combination Therapy.
MRI for Prostate Cancer Local Staging: AJR Expert Panel Narrative Review.
Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data.
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer.
Validation of the PSMA PRIMARY Scoring System and Comparison to an E-PSMA Likert System for [68Ga]Ga-PSMA-11 PET/CT Interpretation in Men With Suspected Radiorecurrent Prostate Cancer.
Image-guided intensity-modulated radiotherapy with reduced margins in patients with prostate cancer: Results of the RCMIGI randomized phase II trial.
Characterising the effect of circulating sphingolipids on metastatic prostate cancer cells.
Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary Endpoints From the EMBARK Trial.
Evaluation of AI for prostate cancer detection in biparametric-MRI screening population data.
Artera Debuts ArteraAI Prostate Test (Post‑RP), Expanding its Oncology Portfolio
Incidence of ideal candidates for focal therapy: A scoping study following the FALCON Consensus Statements.
Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary Endpoints.
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer.
PARP Inhibitors in Prostate Cancer: Broad Use or Patient Selection?
CONNECT WITH US
Questions or Comments? Email us at
editors@urotoday.com
Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523
You are receiving this email because you have chosen to receive emails from UroToday.
Add us to your address book
View this email as a web page
Forward to a colleague
Manage your subscriptions
Unsubscribe
Copyright ©2025 Digital Science Press, LLC
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free